{"id":7488,"date":"2025-08-08T11:13:30","date_gmt":"2025-08-08T09:13:30","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/us\/?post_type=clinical-trial&p=7488"},"modified":"2025-08-08T11:13:30","modified_gmt":"2025-08-08T09:13:30","slug":"rationale-302-trial","status":"publish","type":"clinical-trial","link":"https:\/\/beonemedaffairs.com\/us\/clinical-trial\/7488\/rationale-302-trial\/","title":{"rendered":"RATIONALE-302 Trial"},"content":{"rendered":"","protected":false},"template":"","post-tag":[],"class_list":["post-7488","clinical-trial","type-clinical-trial","status-publish","hentry","content_type-reading","disease_state-esophageal-squamous-cell-carcinoma","molecule-tislelizumab"],"acf":{"summary":"RATIONALE-302 (NCT03430843) is a global Phase 3 study of tislelizumab vs investigator-chosen chemotherapy as a second-line (2L) treatment for advanced unresectable\/metastatic esophageal squamous cell carcinoma (ESCC).","study_status":"complete","cancer_type":false,"authors":"","related_posts":[{"id":7467,"title":"RATIONALE-302 Trial","title_guest":"","summary":"RATIONALE-302 (NCT03430843) is a global Phase 3 study of tislelizumab vs investigator-chosen chemotherapy as a second-line (2L) treatment for advanced unresectable\/metastatic esophageal squamous cell carcinoma (ESCC).","summary_guest":"","content-type":4,"post_image":7468,"blur_thumbnail_guest":false,"post_image_guest":false,"videolange":null,"url":"https:\/\/beonemedaffairs.com\/us\/7467\/rationale-302-trial\/","date":"2025-08-08T10:45:27","date_gmt":"2025-08-08T08:45:27"}],"content-type":246,"download_file_reading":null,"display_file_reading":null,"download_file_slidekit":null,"display_file_slidekit":null,"3qsdn":"","webcast":"","videolange":null,"fliphtml_link":""},"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/clinical-trial\/7488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/clinical-trial"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/clinical-trial"}],"acf:term":[{"embeddable":true,"taxonomy":"content_type","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/content_type\/246"}],"acf:post":[{"embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/posts\/7467"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=7488"}],"wp:term":[{"taxonomy":"post-tag","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag?post=7488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}